The above findings indicated that IL-22 noticeably alleviated ovarian disorders, including irregular estrous cycles, polycystic ovaries and aberrant hormone secretion, in non-metabolic PCOS mice in a manner that was relatively independent of improved metabolic function. Here, IL22 is linked to ovarian disorder.